Standout Papers

Diabetes-Driven Atherosclerosis: Updated Mechanistic Insights and Novel Therapeutic Strategies 2025 202612
  1. Diabetes-Driven Atherosclerosis: Updated Mechanistic Insights and Novel Therapeutic Strategies (2025)
    Paschalis Karakasis, Panagiotis Theofilis et al. International Journal of Molecular Sciences

Immediate Impact

3 standout
Sub-graph 1 of 2

Citing Papers

Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement
2025 Standout
Endothelial Dysfunction: Redox Imbalance, NLRP3 Inflammasome, and Inflammatory Responses in Cardiovascular Diseases
2025 Standout
1 intermediate paper

Works of Paschalis Karakasis being referenced

Endothelial Protection by Sodium-Glucose Cotransporter 2 Inhibitors: A Literature Review of In Vitro and In Vivo Studies
2024
Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trials
2023

Author Peers

Author Last Decade Papers Cites
Paschalis Karakasis 280 198 114 80 563
Hideyuki Yoshizumi 106 160 63 40 531
Piotr Książek 162 111 53 41 551
J Gormsen 170 67 83 61 565
Chun Chin Chang 228 128 232 42 626
Hiroaki Sato 173 168 267 56 638
Shinichiro Masuda 459 175 155 51 638
Farina Mohamad Yusoff 185 104 135 73 507
Kwon Sam Kim 336 155 140 49 559
Aivars Lejnieks 109 114 69 90 621
D Hoffmann 114 89 207 40 630

All Works

Loading papers...

Rankless by CCL
2026